ACE Pharmaceuticals has sold a majority stake to private investors and Quadrum Capital
October 2017 — The shareholders of ACE Pharmaceuticals have sold a majority stake in the company to private investors and Quadrum Capital, a Dutch private equity firm.
ACE Pharmaceuticals is a specialized company operating in the niche of medical need products which provide mainly small patient groups or specific indications. Through new, innovative products or by the revitalization of orphaned drugs, the company is able to ensure that these medical need products are or remain available. The company develops and distributes locally and abroad both licensed and non-licensed products. ACE Pharmaceuticals was founded more than 25 years ago as a producer of veterinary medicines. In the early 2000s, the company shifted its focus to human medical need products. Since then, it has experienced strong sales growth and has built an exciting product range and promising product pipeline.
Our role in the transaction
Oaklins's team in the Netherlands acted as M&A advisor to the shareholders of ACE Pharmaceuticals in this transaction.
Talk to the deal team
Sander van 't Spijker
Oaklins Netherlands
Related deals
Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Learn moreLife & Mobility has attracted investor Bolster Investment Partners
Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.
Learn moreAsana Gruppe has sold selected outpatient service areas to Luzerner Kantonsspital
Luzerner Kantonsspital (LUKS) has acquired key parts of Asana Spital Menziken AG’s outpatient services from Asana Gruppe AG, including its ambulance service, primary care practice and ambulatory care center. The transaction supports the long-term continuity of local medical care in the Swiss Wynen and Seetal regions and ensures these services remain available close to patients’ homes.
Learn more